Azenta receives full repayment of $35 million vendor loan
- Azenta (NASDAQ:AZTA) received full repayment of a $35 million secured vendor loan related to the sale of B Medical Systems.
- The repayment completes Azenta’s cash collection of the $63 million B Medical Systems purchase price.
- The company said the credit exposure connected to the transaction has been retired.
Azenta (NASDAQ:AZTA) received full early repayment of a $35 million secured vendor loan related to the sale of B Medical Systems to Thelema S.à r.l.
The loan was provided by Azenta Germany GmbH, a wholly owned subsidiary of Azenta, as part of the transaction that closed on July 1, 2026.
Azenta stated that the loan, which was secured by a pledge over B Medical Systems’ equity interests, was repaid in full along with all accrued interest, and the related share pledge was released.
The repayment means Azenta has now received the full $63 million purchase price for B Medical Systems in cash, while eliminating the remaining credit exposure from the transaction.
The repayment concludes the financial arrangements associated with Azenta’s divestiture of B Medical Systems and converts the transaction proceeds into completed cash receipts.
Azenta provides life sciences solutions, including products and services used in sample management, laboratory automation, and biological storage applications.
Frequently asked questions
More from United States
AbbVie revenue increases 10.3% to $17.4 billion in third quarter
Sensient Q3 revenue rockets 10.6% to $455.8 million
Cameco Q3 adjusted loss reaches CA$2 million as uranium output falls
Kite Realty Q3 loss narrows to $13.3 million as NOI grows
Largo cuts 2026 vanadium production outlook to 9,500–10,500 tonnes
nVent Q3 sales jump 44% as shares fall despite higher revenue
